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sons and persons born in the United
States), for whom the difference from
NHANES III to NHANES 1999–
2000 data reached statistical signifi-
cance at p<0.05 in the t test, but the
95% confidence intervals (CIs) for the
prevalence estimates for these groups
still overlapped between NHANES III
and NHANES 1999–2000 (i.e., the t
test is a less conservative measure of
association than CI). 
After this correction, the overall
age-adjusted T. gondii antibody
prevalence according to NHANES
1999–2000 data changed from 15.8%
(95% CI 13.5%–18.1%) to 14.3%
(95% CI 12.3%–16.2%). The Table
shows the overall and stratified sero-
prevalence rates for NHANES
1999–2000 (corrected) compared
with NHANES III (no corrections
needed). 
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Human Infection
with Schineria 
larvae
To the Editor: Myiasis remains
prevalent worldwide (1,2) and is
infestation by larvae from fly species
of live or dead tissues from vertebrate
hosts (1,3,4). In humans, myiasis
most frequently causes infection of
exposed ulcers or traumatic wounds
(1). In industrialized countries, most
cases occur in tourists returning from
tropical and subtropical areas (5,6),
but autochthonous cases still exist.
Several bacterial species have been
associated with fly larvae, including
species of the family Enterobac-
teriaceae and, more recently,
Schineria larvae (7,8). S. larvae, a
gram-negative bacterium, has been
grown from larvae of Wohlfahrtia
magnifica, a fly species responsible
for myiasis (7,8). Its 16S rRNA gene
has been amplified from a bacterial
community of species involved in aer-
obic thermophilic bioprocesses (9).
We report a case of S. larvae bac-
teremia in a man with wound myiasis.
On June 12, 2006, a 76-year-old
man who had type 2 diabetes mellitus
was examined at the emergency
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department of Drôme North
Hospitals, Romans, France, for
inflammation of chronic cutaneous
ulcers of both legs and intermittent
fever. The patient lived alone in a
rural, crowded area and had received
no medical care. He reported owning
sheep and denied any recent travel
outside France. At the time of admis-
sion, his body temperature was
37.8°C, he was malodorous, and he
had swelling and painful wounds on
both legs. Maggots were found in the
leg wounds, scrotum ulcers, and at the
anal margin. A radiographic examina-
tion of both legs did not show any
osteolytic lesion. Laboratory data
were as follows: C-reactive protein 71
mg/L (reference value, <5 mg/L),
leukocyte count 18.2 × 109/L (81%
granulocytes), platelet and erythro-
cyte counts within normal limits, glu-
cose 200 mg/dL, hemoglobin A1c
level 13.8%. Serum protein elec-
trophoresis showed hypoalbuminemia
(20 g/L) and hypergammaglobuline-
mia (16.9 g/L) but no monoclonal
gammopathy. Two blood samples and
exudate from the leg wounds were
collected for microbial cultures.
The patient was given a combina-
tion of amoxicillin-clavulanate and
ofloxacin, and his cutaneous wounds
were cleaned. After 24 h of incuba-
tion, leg wound cultures grew methi-
cillin-susceptible Staphylococcus
aureus, and the 2 blood cultures yield-
ed the same S. aureus strain and an
oxidative gram-negative bacterium
(Romans strain). The Romans strain
was found to be highly susceptible to
β-lactams, aminoglycosides, chloram-
phenicol, cotrimoxazole, fluoro-
quinolones, and colistin. The antimi-
crobial drug therapy was changed to
oxacillin and ofloxacin. The patient’s
condition improved rapidly, and his
leg wounds healed progressively dur-
ing hospitalization. He was dis-
charged 27 days after initiation of
antimicrobial therapy, which he con-
tinued for 7 more days. The patient
was reexamined 1 month later and
was considered cured.
The Romans strain was sent to
the bacteriology laboratory at
Grenoble University Hospital for
identification. Using the API 20NE
and Vitek II ID-GNB systems
(bioMérieux, Marcy L’Etoile,
France), we obtained, respectively, a
“good” identification of Psychro-
bacter phenylpyruvicus and a “very
good” identification of Oligella ure-
olytica. The nearly complete 16S
rRNA gene of the Romans strain was
amplified and sequenced; primers
were Fd1 and rp2 (10) (GenBank
accession no. EF120377). A BLAST
search that used the network service
of the National Center for
Biotechnology Information (www.
ncbi.nlm.nih.gov) showed 99.6%
identity between the determined gene
sequence of 16S rRNA and that of S.
larvae type strain L1/68T (accession
no. AJ252143). The 16S rRNA gene
sequences from several species
belonging to the Gamma Proteo-
bacteria order were aligned by using
the ClustalW package (www.ncbi.
nlm.nih.gov/). A consensus phyloge-
netic tree was constructed from Jukes-
Cantor evolutionary distances based
on the neighbor-joining method using
Bacillus subtilis as the root. The
Romans strain clustered with previ-
ously characterized S. larvae strains
(Figure).
Our report demonstrates that S.
larvae can induce bacteremia in
humans. Because S. larvae has been
associated with only fly larvae, we
can speculate that bacteremia origi-
nated from maggots infesting the
patient’s wounds. We cannot affirm
that W. magnifica was the fly species
involved because maggots were not
saved for identification. Phenotypic
identification of S. larvae is tedious
(7). Because it is an asaccharolytic
species, erroneous identification may
occur. We can speculate that difficul-
ties in phenotypic identification of
this species may explain why it has
not been previously reported as a
potential human or animal pathogen.
In conclusion, myiasis remains
an unresolved problem in animals and
humans worldwide. Physicians and
microbiologists should be aware of
the possibility of S. larvae bacteremia
and should specifically search for S.
larvae infection in myiasis patients.
Also, animal myiasis is still responsi-
ble for severe economic losses to the
livestock industry worldwide. The
occurrence of S. larvae bacteremia in
animals with myiasis may explain the
evolution from disease to death, espe-
cially in chronically infected animals.
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Figure. Phylogenetic position of the Romans strain within the Gamma Proteobacteria,
determined by using Jukes-Cantor evolutionary distance calculation and neighbor-joining
tree method. Bootstrap values (based on 500 steps) are indicated. GenBank accession
no. of 16S rRNA gene of each bacterial species is indicated in parentheses.
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Isolation of
Schineria sp. from
a Man 
To the Editor: Schineria larvae
has been isolated from maggots of the
fly Wohlfahrtia magnifica (1), which
cause myiasis in animals and people
in Eurasia and northern Africa. In
industrialized nontropical countries, a
range of species in the order Diptera
cause facultative myiasis in patients
with neglected wounds (2). Since the
recent description of S. larvae,
Schineria sp. isolates and clones have
been detected in diverse environmen-
tal and animal sources, but in all cases
a relation with flies could be estab-
lished. We describe a case of bac-
teremia due to Schineria sp. in a
human patient with myiasis.
In July 2005, a 39-year-old
homeless man with medical history of
polyneuropathy related to alcohol
abuse was examined at Montpellier
Hospital, Montpellier, France, and
found to be in poor general health and
to have an abnormal electrocardio-
gram, mild fever (38°C), metabolic
disorders, increased C-reactive pro-
tein (254 mg/L) and fibrinogen (18.23
µmol/L), and a normal leukocyte
count (7.8 × 109/L). Removal of his
shoes and socks, which he had worn
continuously for 2 months, showed
advanced maceration of his feet
(trench foot) with wounds invaded by
maggots. The following organisms
were found in wound samples:
Proteus mirabilis, Providentia stuartii,
group G Streptococcus, Streptococcus
sp., and Enterococcus sp. Aerobic
blood culture, after 2 days of incuba-
tion, was positive for a gram-negative
rod, strain ADV1107. 05. Subculture
on MacConkey medium showed posi-
tive reactions for oxidase, catalase,
and gamma-glutamyltransferase.
Positive malate reaction with API
20NE system (bioMérieux, Marcy
l’Etoile, France) identified the strain
as Oligella urethralis, whereas
VITEK2 (bioMérieux) with ID-GN
card failed to identify the strain. Disk
diffusion assay showed the strain to
be susceptible to β-lactams, amino-
glycosides, fluoroquinolones, tetracy-
clines, erythromycin, rifampin, and
colistin but resistant to nalidixic acid
and fosfomycin. Local therapy of
debridement, bandaging, and sulfadi-
azin argentic, along with systemic
antimicrobial therapy (ofloxacin 400
mg/day plus cefotaxime 6 g/day) for 2
weeks, led to clinical improvement
and sterilization of the blood cultures.
The local therapy was continued, and
ofloxacin (400 mg/day) was pre-
scribed for 15 days while the patient
was in a rehabilitation center. 
In October 2005, the patient was
readmitted with the same symptoms.
P. mirabilis, group A and group G
streptococci, Morganella sp.,
Bacteroides fragilis, and Candida
albicans were cultured from maggot-
invaded wounds. Aerobic blood cul-
ture, after 1 day of incubation, was
positive for strain ADV4155.05,
which displayed the same phenotype
as strain ADV1107.05 except for
tetracycline resistance. Clinical
improvement was observed after 2
weeks of the same local and systemic
treatments as initially prescribed. The
patient was transferred to an addiction
care center and received oral antimi-
crobial therapy (ciprofloxacin 500
mg/day plus amoxicillin/clavulanic
acid 3 g/day) for 20 days.
The 16S rDNA amplification and
sequencing were performed with uni-
versal primers 27f and 1492r as
described (3). The 1,414-bp sequences
of the 2 isolates were identical and
showed similarity level of 99.6% with
the sequence of Schineria sp.
010793816 isolated from human urine
(M. Vaneechoutte, pers. comm.) but
only 98.3% with S. larvae L1/68T 16S
rDNA. This finding differed from the
biochemical identification and under-
lined the usefulness of sequencing to
precisely identify gram-negative
bacilli that assimilate only a few
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